Signalway Antibody has developed an unique monoclonal antibody technology which is named as Recombinant Monoclonal and Single B Cell Antibody (RmSab™) Technology. This technology employs a whole set of optimized methods including single B cell sorting, enriching and proliferation, applications screening and validation, and gene cloning, sequencing and expression. It is inaccessible to traditional hybridoma technology, and is faster with high success rate and high antibody affinity compared to general single B cell sorting, enriching and sequencing technology.
This revolutionary method has successfully been applied to develop high quality recombinant rabbit monoclonal antibodies as well as other hosts. Our mission is to promote personal health and advancing disease diagnosis by providing superior monoclonal antibodies to our customers in the research and diagnostic fields.